☰

Amanda W. Lund, Ph.D. - Publications

Affiliations: 
2004-2009 Biology and Biomedical Engineering Rensselaer Polytechnic Institute, Troy, NY, United States 
 2009-2014 Institute of Biological Engineering and ISREC Swiss Federal Institute of Technology (EPFL) 
 2014-2020 Cell, Developmental, and Cancer Biology Oregon Health and Science University, Portland, OR 
 2020- Dermatology New York University School of Medicine 
Area:
Cancer Immunology
Website:
www.thelundlab.com
Tree Info Similar researchers PubMed Report error

58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Heim TA, Schultz AC, Delclaux I, Cristaldi V, Churchill MJ, Ventre KS, Lund AW. Lymphatic vessel transit seeds cytotoxic resident memory T cells in skin draining lymph nodes. Science Immunology. 9: eadk8141. PMID 38848340 DOI: 10.1126/sciimmunol.adk8141  0.752
2024 Broz MT, Ko EY, Ishaya K, Xiao J, De Simone M, Hoi XP, Piras R, Gala B, Tessaro FHG, Karlstaedt A, Orsulic S, Lund AW, Chan KS, Guarnerio J. Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nature Communications. 15: 2498. PMID 38509063 DOI: 10.1038/s41467-024-46504-4  0.419
2023 Heim TA, Schultz AC, Delclaux I, Cristaldi V, Churchill MJ, Lund AW. Lymphatic vessel transit seeds precursors to cytotoxic resident memory T cells in skin draining lymph nodes. Biorxiv : the Preprint Server For Biology. PMID 37693469 DOI: 10.1101/2023.08.29.555369  0.751
2023 Cristaldi V, Lund AW. Structural Vulnerabilities in DLBCL for Enhanced Treatment Strategies. Cancer Research. 83: 2643-2644. PMID 37404051 DOI: 10.1158/0008-5472.CAN-23-1956  0.376
2023 Park HR, Shiva A, Cummings P, Kim S, Kim S, Lee E, Leong A, Chowdhury S, Shawber C, Carvajal R, Thurston G, An JY, Lund AW, Yang HW, Kim M. Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma. Cancer Research. PMID 37093870 DOI: 10.1158/0008-5472.CAN-22-2838  0.401
2023 Steele MM, Jaiswal A, Delclaux I, Dryg ID, Murugan D, Femel J, Son S, du Bois H, Hill C, Leachman SA, Chang YH, Coussens LM, Anandasabapathy N, Lund AW. Author Correction: T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nature Immunology. PMID 36932125 DOI: 10.1038/s41590-023-01491-4  0.781
2023 Steele MM, Jaiswal A, Delclaux I, Dryg ID, Murugan D, Femel J, Son S, du Bois H, Hill C, Leachman SA, Chang YH, Coussens LM, Anandasabapathy N, Lund AW. T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nature Immunology. PMID 36849745 DOI: 10.1038/s41590-023-01443-y  0.789
2023 Heim TA, Lin Z, Steele MM, Mudianto T, Lund AW. CXCR6 promotes dermal CD8 T cell survival and transition to long-term tissue residence. Biorxiv : the Preprint Server For Biology. PMID 36824892 DOI: 10.1101/2023.02.14.528487  0.32
2023 Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, Beri N, Khanna L, Gonda T, Oberstein P, Hajdu C, ... ... Lund AW, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 797. PMID 36781852 DOI: 10.1038/s41467-023-36296-4  0.34
2022 Barkley D, Moncada R, Pour M, Liberman DA, Dryg I, Werba G, Wang W, Baron M, Rao A, Xia B, França GS, Weil A, Delair DF, Hajdu C, Lund AW, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nature Genetics. 54: 1192-1201. PMID 35931863 DOI: 10.1038/s41588-022-01141-9  0.772
2022 Blair TC, Bambina S, Kramer GF, Dowdell AK, Alice AF, Baird JR, Lund AW, Piening BD, Crittenden MR, Gough MJ. Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy. Life Science Alliance. 5. PMID 35487695 DOI: 10.26508/lsa.202101337  0.311
2022 Moldoveanu D, Ramsay L, Lajoie M, Anderson-Trocme L, Lingrand M, Berry D, Perus LJM, Wei Y, Moraes C, Alkallas R, Rajkumar S, Zuo D, Dankner M, Xu EH, Bertos NR, ... ... Lund AW, et al. Spatially mapping the immune landscape of melanoma using imaging mass cytometry. Science Immunology. 7: eabi5072. PMID 35363543 DOI: 10.1126/sciimmunol.abi5072  0.408
2022 Churchill MJ, du Bois H, Heim TA, Mudianto T, Steele MM, Nolz JC, Lund AW. Infection-induced lymphatic zippering restricts fluid transport and viral dissemination from skin. The Journal of Experimental Medicine. 219. PMID 35353138 DOI: 10.1084/jem.20211830  0.74
2021 Ngamcherdtrakul W, Reda M, Nelson MA, Wang R, Zaidan HY, Bejan DS, Hoang NH, Lane RS, Luoh SW, Leachman SA, Mills GB, Gray JW, Lund AW, Yantasee W. In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response. Advanced Materials (Deerfield Beach, Fla.). e2100628. PMID 34118167 DOI: 10.1002/adma.202100628  0.599
2020 Soloff AC, Jones KE, Powers AA, Murthy P, Wang Y, Russell KL, Byrne-Steele M, Lund AW, Yuan JM, Monaco SE, Han J, Dhupar R, Lotze MT. HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions. Frontiers in Immunology. 11: 2027. PMID 33013860 DOI: 10.3389/Fimmu.2020.02027  0.465
2020 Lund AW. Abstract IA19: Lymphatic vessels: Barriers to adaptive immunity in melanoma Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-Ia19  0.496
2020 Lane RS, Breazeale AP, Lund AW. Abstract A78: IFNg-activated lymphatic vessels express PD-L1 and suppress effector T-cell function in melanoma Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A78  0.684
2019 O'Melia MJ, Lund AW, Thomas SN. The Biophysics of Lymphatic Transport: Engineering Tools and Immunological Consequences. Iscience. 22: 28-43. PMID 31739172 DOI: 10.1016/J.Isci.2019.11.005  0.347
2019 Leachman SA, Hornyak TJ, Barsh G, Bastian BC, Brash DE, Cleaver JE, Cooper CD, D'Orazio JA, Fujita M, Holmen SL, Indra AK, Kramer KH, Le Poole IC, Lo RS, Lund AW, et al. Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting. The Journal of Investigative Dermatology. PMID 31348921 DOI: 10.1016/J.Jid.2019.03.1164  0.306
2019 Steele MM, Churchill MJ, Breazeale AP, Lane RS, Nelson NA, Lund AW. Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors. Journal of Visualized Experiments : Jove. PMID 30663703 DOI: 10.3791/58704  0.783
2018 Lane RS, Lund AW. Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors. Frontiers in Immunology. 9: 2662. PMID 30498499 DOI: 10.3389/Fimmu.2018.02662  0.701
2018 Lane RS, Femel J, Breazeale AP, Loo CP, Thibault G, Kaempf A, Mori M, Tsujikawa T, Chang YH, Lund AW. IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. The Journal of Experimental Medicine. PMID 30381467 DOI: 10.1084/Jem.20180654  0.714
2018 Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M, Adriaens C, Radaelli E, Wolter P, Bechter O, Dummer R, ... ... Lund AW, et al. Toward Minimal Residual Disease-Directed Therapy in Melanoma. Cell. PMID 30017245 DOI: 10.1016/J.Cell.2018.06.025  0.331
2017 Loo CP, Nelson NA, Lane RS, Booth JL, Loprinzi Hardin SC, Thomas A, Slifka MK, Nolz JC, Lund AW. Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection. Cell Reports. 20: 3176-3187. PMID 28954233 DOI: 10.1016/J.Celrep.2017.09.006  0.621
2017 Fankhauser M, Broggi MAS, Potin L, Bordry N, Jeanbart L, Lund AW, Da Costa E, Hauert S, Rincon-Restrepo M, Tremblay C, Cabello E, Homicsko K, Michielin O, Hanahan D, Speiser DE, et al. Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Science Translational Medicine. 9. PMID 28904226 DOI: 10.1126/Scitranslmed.Aal4712  0.522
2017 Lund AW. Winter is coming: Tumor cells go into hibernation. Science Translational Medicine. 9. PMID 28202775 DOI: 10.1126/Scitranslmed.Aam6063  0.409
2017 Femel J, Tsujikawa T, Thibault G, Booth J, Lund AW. Abstract A19: Lymphatic vessels as a biomarker in human melanoma Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-A19  0.472
2017 Lane RS, Femel J, Booth J, Loo C, Nelson N, Tsujikawa T, Thibault G, Lund AW. Abstract NG02: Lymphatic vessels: Balancing immune priming and immune evasion in melanoma Immunology. 77. DOI: 10.1158/1538-7445.Am2017-Ng02  0.6
2016 Lund AW. Rethinking Lymphatic Vessels and Antitumor Immunity. Trends in Cancer. 2: 548-551. PMID 28741486 DOI: 10.1016/J.Trecan.2016.09.005  0.395
2016 Lund AW. The lung's defensive line. Science Translational Medicine. 8: 365ec184. PMID 27856793 DOI: 10.1126/Scitranslmed.Aal0072  0.304
2016 Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, Gajewski TF, Alitalo K, Eikesdal HP, Wiig H, Swartz MA. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. The Journal of Clinical Investigation. PMID 27525437 DOI: 10.1172/Jci79434  0.556
2016 Pearson YE, Lund AW, Lin A, Ng CP, Alsuwaidi A, Azzeh S, Gater DL, Teo J. Non-invasive single cell biomechanical analysis using live imaging datasets. Journal of Cell Science. PMID 27422102 DOI: 10.1242/Jcs.191205  0.441
2016 Lund AW, Medler TR, Leachman SA, Coussens LM. Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer. Cancer Discovery. 6: 22-35. PMID 26552413 DOI: 10.1158/2159-8290.Cd-15-0023  0.367
2016 Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Lund AW, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6  0.549
2016 Lund AW. Working for Tip(DC)s Science Translational Medicine. 8: 359ec160-359ec160. DOI: 10.1126/Scitranslmed.Aai8747  0.504
2016 Lund AW. Re-energizing exhausted T cells? Science Translational Medicine. 8: 353ec135-353ec135. DOI: 10.1126/Scitranslmed.Aah5499  0.482
2016 Lund AW. NK cells: A new player for the defense Science Translational Medicine. 8: 347ec111-347ec111. DOI: 10.1126/Scitranslmed.Aah3545  0.408
2016 Lund AW. The good and bad of T cell promiscuity Science Translational Medicine. 8: 341ec88-341ec88. DOI: 10.1126/Scitranslmed.Aag1704  0.4
2016 Lund AW. AID-ing inflammatory carcinogenesis Science Translational Medicine. 8: 335ec65-335ec65. DOI: 10.1126/Scitranslmed.Aaf7823  0.4
2015 Lund A, Wagner M, Fankhauser M, Wiig H, Swartz M. Abstract PR02: Dermal lymphatic vessels are required for the induction of local inflammation in a B16 F10 murine melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr02  0.592
2014 Güç E, Fankhauser M, Lund AW, Swartz MA, Kilarski WW. Long-term intravital immunofluorescence imaging of tissue matrix components with epifluorescence and two-photon microscopy. Journal of Visualized Experiments : Jove. PMID 24797928 DOI: 10.3791/51388  0.551
2014 Hirosue S, Vokali E, Raghavan VR, Rincon-Restrepo M, Lund AW, Corthésy-Henrioud P, Capotosti F, Halin Winter C, Hugues S, Swartz MA. Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells. Journal of Immunology (Baltimore, Md. : 1950). 192: 5002-11. PMID 24795456 DOI: 10.4049/Jimmunol.1302492  0.548
2014 Thomas SN, Vokali E, Lund AW, Hubbell JA, Swartz MA. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response Biomaterials. 35: 814-824. PMID 24144906 DOI: 10.1016/J.Biomaterials.2013.10.003  0.543
2013 Kilarski WW, Güç E, Teo JCM, Oliver SR, Lund AW, Swartz MA. Intravital Immunofluorescence for Visualizing the Microcirculatory and Immune Microenvironments in the Mouse Ear Dermis Plos One. 8. PMID 23451163 DOI: 10.1371/Journal.Pone.0057135  0.569
2012 Lund AW, Duraes FV, Hirosue S, Raghavan VR, Nembrini C, Thomas SN, Issa A, Hugues S, Swartz MA. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Reports. 1: 191-9. PMID 22832193 DOI: 10.1016/J.Celrep.2012.01.005  0.58
2012 Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nature Reviews. Cancer. 12: 210-9. PMID 22362216 DOI: 10.1038/Nrc3186  0.475
2012 Swartz MA, Lund AW, Shields JD, Kourtis IC, Hirosue S. Abstract 298: Tumor-associated lymphatic vessels: Hijacking mechanisms of peripheral tolerance Cancer Research. 72: 298-298. DOI: 10.1158/1538-7445.Am2012-298  0.496
2011 Lund AW, Raghavan V, Hirosue S, Duraes F, Hugues S, Swartz M. Abstract LB-151: Tumor VEGF-C promotes immune suppression and tolerance Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-151  0.567
2010 Bilgin CC, Lund AW, Can A, Plopper GE, Yener B. Quantification of three-dimensional cell-mediated collagen remodeling using graph theory. Plos One. 5. PMID 20927339 DOI: 10.1371/Journal.Pone.0012783  0.705
2010 Solorio L, Zwolinski C, Lund AW, Farrell MJ, Stegemann JP. Gelatin microspheres crosslinked with genipin for local delivery of growth factors. Journal of Tissue Engineering and Regenerative Medicine. 4: 514-23. PMID 20872738 DOI: 10.1002/Term.267  0.603
2010 Lund AW, Swartz MA. Role of lymphatic vessels in tumor immunity: passive conduits or active participants? Journal of Mammary Gland Biology and Neoplasia. 15: 341-52. PMID 20835756 DOI: 10.1007/S10911-010-9193-X  0.547
2009 Lund AW, Stegemann JP, Plopper GE. Mesenchymal Stem Cells Sense Three Dimensional Type I Collagen through Discoidin Domain Receptor 1. The Open Stem Cell Journal. 1: 40-53. PMID 20589230 DOI: 10.2174/1876893800901010040  0.767
2009 Lund AW, Bilgin CC, Hasan MA, McKeen LM, Stegemann JP, Yener B, Zaki MJ, Plopper GE. Quantification of spatial parameters in 3D cellular constructs using graph theory. Journal of Biomedicine & Biotechnology. 2009: 928286. PMID 19920859 DOI: 10.1155/2009/928286  0.715
2009 Lund AW, Yener B, Stegemann JP, Plopper GE. The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Engineering. Part B, Reviews. 15: 371-80. PMID 19505193 DOI: 10.1089/Ten.Teb.2009.0270  0.759
2009 Lund AW, Stegemann JP, Plopper GE. Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three-dimensional collagen I culture. Stem Cells and Development. 18: 331-41. PMID 18491946 DOI: 10.1089/Scd.2008.0075  0.75
2008 Lund AW, Bush JA, Plopper GE, Stegemann JP. Osteogenic differentiation of mesenchymal stem cells in defined protein beads. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 87: 213-21. PMID 18431753 DOI: 10.1002/Jbm.B.31098  0.758
2006 PLOPPER G, KLEES R, WARD D, LUND A, WILLIAMS W, STEGEMANN J, AGIUS P, BERGERON C, BENNETT K, ROYSAM B. Deciphering ECM_induced differentiation of adult human stem cells Matrix Biology. 25: S22-S22. DOI: 10.1016/J.Matbio.2006.08.062  0.733
2005 Batorsky A, Liao J, Lund AW, Plopper GE, Stegemann JP. Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments. Biotechnology and Bioengineering. 92: 492-500. PMID 16080186 DOI: 10.1002/Bit.20614  0.757
Show low-probability matches.